Frontiers in Cardiovascular Medicine (Oct 2021)

Virtual (Computed) Fractional Flow Reserve: Future Role in Acute Coronary Syndromes

  • Hazel Arfah Haley,
  • Hazel Arfah Haley,
  • Hazel Arfah Haley,
  • Mina Ghobrial,
  • Mina Ghobrial,
  • Paul D. Morris,
  • Paul D. Morris,
  • Paul D. Morris,
  • Rebecca Gosling,
  • Rebecca Gosling,
  • Gareth Williams,
  • Gareth Williams,
  • Mark T. Mills,
  • Mark T. Mills,
  • Tom Newman,
  • Tom Newman,
  • Vignesh Rammohan,
  • Vignesh Rammohan,
  • Giulia Pederzani,
  • Giulia Pederzani,
  • Patricia V. Lawford,
  • Patricia V. Lawford,
  • Rodney Hose,
  • Rodney Hose,
  • Julian P. Gunn,
  • Julian P. Gunn,
  • Julian P. Gunn

DOI
https://doi.org/10.3389/fcvm.2021.735008
Journal volume & issue
Vol. 8

Abstract

Read online

The current management of acute coronary syndromes (ACS) is with an invasive strategy to guide treatment. However, identifying the lesions which are physiologically significant can be challenging. Non-invasive imaging is generally not appropriate or timely in the acute setting, so the decision is generally based upon visual assessment of the angiogram, supplemented in a small minority by invasive pressure wire studies using fractional flow reserve (FFR) or related indices. Whilst pressure wire usage is slowly increasing, it is not feasible in many vessels, patients and situations. Limited evidence for the use of FFR in non-ST elevation (NSTE) ACS suggests a 25% change in management, compared with traditional assessment, with a shift from more to less extensive revascularisation. Virtual (computed) FFR (vFFR), which uses a 3D model of the coronary arteries constructed from the invasive angiogram, and application of the physical laws of fluid flow, has the potential to be used more widely in this situation. It is less invasive, fast and can be integrated into catheter laboratory software. For severe lesions, or mild disease, it is probably not required, but it could improve the management of moderate disease in 'real time' for patients with non-ST elevation acute coronary syndromes (NSTE-ACS), and in bystander disease in ST elevation myocardial infarction. Its practicability and impact in the acute setting need to be tested, but the underpinning science and potential benefits for rapid and streamlined decision-making are enticing.

Keywords